Homburger advises Santhera in CHF 45 m Financing

On September 22, 2021, Santhera Pharmaceuticals Holding AG (SIX: SANN) announced an equity financing of CHF 20 m via a private placement of shares, a placement of private convertible bonds of CHF 15 m and upsizing of an existing financing arrangement of up to CHF 10 m. In addition, Santhera agreed to issue warrants to participating investors.

Homburger advised Santhera in this matter. The team was led by partners Dieter Gericke and Daniel Häusermann (both Capital Markets). Key members of the team included partner Stefan Oesterhelt (Tax), counsel Eduard De Zordi (Capital Markets), associates Margrit Marti, Francesco Bernasconi and Romain Fakhoury (all Capital Markets), as well as junior associate Natalie Pompe.